Distribution and pathogenicity of nsSNPs in receptor tyrosine kinases (RTKs) in non-small cell lung cancer (NSCLC) patients (pts)

被引：1
|
作者：
Vanderwalde, Ari M.
Stein, Matthew K.
Morris, Lindsay Kaye
Sareen, Srishti
Karri, Saradasri
Patel, Kruti
Sullivan, Jennifer
Schwartzberg, Lee Steven
Martin, Michael Gary
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e20618
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20618
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Distribution and pathogenicity of nsSNPs in receptor tyrosine kinases (RTKs) in patients with colorectal cancer.
    Stein, Matthew K.
    Karri, Saradasri
    Morris, Lindsay Kaye
    Sareen, Srishti
    Patel, Kruti
    Daugherty, Ray Scott
    Shibata, David
    Vanderwalde, Ari M.
    Schwartzberg, Lee Steven
    Martin, Michael Gary
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Innate resistance in EGFR mutant non-small cell lung cancer (NSCLC) patients by coactivation of receptor tyrosine kinases (RTKs)
    Rosell, R.
    Karachaliou, N.
    Chaib, I.
    Drozdowskyj, A.
    Frias, A.
    Teixido, C.
    Viteri, S.
    Santarpia, L.
    Molina-Vila, M. A.
    Bivona, T. G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Prognostic significance of aneuploidy in non-small cell lung cancer (NSCLC) patients (pts).
    Dziadziuszko, R
    Wegrzynowicz, E
    Kardas, I
    Limon, J
    Jassem, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 695S - 695S
  • [4] The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis G.
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    Castro, Gilberto
    De Marchi, Pedro
    Felip, Enriqueta
    Goto, Yasushi
    Greystoke, Alastair
    Lu, Shun
    Lim, Darren Wan Teck
    Papadimitrakopoulou, Vassiliki
    Reck, Martin
    Solomon, Benjamin J.
    Spigel, David R.
    Tan, Daniel Shao-Weng
    Thomas, Michael
    Yang, James Chih-Hsin
    Johnson, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [6] Innate resistance in EGFR mutant non-small-cell lung cancer patients by co-activation of receptor tyrosine kinases(RTKs)
    Karachaliou, Niki
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer
    Müller-Tidow, C
    Diederichs, S
    Bulk, E
    Pohle, T
    Steffen, B
    Schwäble, J
    Plewka, S
    Thomas, M
    Metzger, R
    Schneider, PM
    Brandts, CH
    Berdel, WE
    Serve, H
    CANCER RESEARCH, 2005, 65 (05) : 1778 - 1782
  • [8] Trends in demographics and survival for patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Kubota, K.
    Masuhara, H.
    Hosoya, K.
    Yoh, K.
    Niho, S.
    Goto, K.
    Ohmatsu, H.
    Nishiwaki, Y.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 392S - 392S
  • [9] Epidermal growth factor receptor (EGFR) mutation testingin non-small cell lung cancer (NSCLC) patients (pts).
    Sequist, L. V.
    Joshi, V. A.
    Jänne, P. A.
    Fidias, P.
    Muzikansky, A.
    Meyerson, M.
    Haber, D. A.
    Kucherlapati, R.
    Johnson, B. E.
    Lynch, T. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [10] Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, Hye Ryun
    Gridelli, Cesare
    Kapur, Dinesh
    Tufman, Amanda
    Felip, Enriqueta
    Velcheti, Vamsidhar
    Kim, Yu Jung
    Goetze, Thorsten
    Lopez, Pilar Garrido
    Corre, Romain
    Penkov, Konstantin
    Anjum, Rana
    Di Pace, Brian
    Liu, Wenlei
    Borgovan, Theo
    Ledger, Danielle
    Carver, Jennifer
    Waszak, Angela
    Dhar, Arindam
    Novello, Silvia
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 163 - 163
12345